TLPH Q1 2019 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$265,000-22.7% YoY

Gross Profit

-$2M-883.8% margin

Operating Income

-$12M-4648.3% margin

Net Income

-$14M-5160.0% margin

EPS (Diluted)

$-3.47

QoQ Revenue Growth

-56.8%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$113M

Total Liabilities

$121M

Stockholders' Equity

-$8M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$265,000	$343,000	-22.7%
Gross Profit	-$2M	-$4M	+45.3%
Operating Income	-$12M	-$8M	-49.0%
Net Income	-$14M	-$12M	-18.0%